Sign up to save your podcasts
Or
Share Dr RR Baliga's "Got Knowledge Doc" Podkast
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Dr RR Baliga's "Got Knowledge Doc" Podkast
Dr RR Baliga's "Got Knowledge Doc" Podkast episodes
- Jugular Venous Pulse
🎧 Dr RR Baliga's Internal Medicine Podcasts for Physicians: MUST KNOW FACTs about Jugular Venous Pulse
Not Medical Advice or Opinion
16 min - Artificial Intelligence & Machine Learning Primer for PHYSICIANS
Artificial Intelligence & Machine Learning Primer for PHYSICIANS
Dr RR Baliga's GOT KNOWLEDGE DOC PodKasts
associated with
Baliga's Textbook of Medicine with 1480 MCQs
available at
www.MasterMedFacts.com
27 min - Sodium Glucose Transporter-2 (SGLT2) Inhibition to Prevent Cardiotoxicity?
Sodium Glucose Transporter-2 (SGLT2) Inhibition to Prevent Chemotherapy Induced Cardiotoxicity?
Dr RR Baliga's 'Got Knowledge Doc' PodKasts for Physicians
References
Scafoglio C, et al. Functional expression of sodium-glucose transporters in cancer. Proc Natl Acad Sci U S A. 2015
Scafoglio CR, et al. Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma. Sci Transl Med. 2018
Martinez CA, Scafoglio C. Heterogeneity of Glucose Transport in Lung Cancer. Biomolecules. 2020
Paternostro G, Camici PG, Lammerstma AA, Baliga RR, et al. Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography. J Clin Invest. 1996;98(9):2094‐2099.
Bassi NS, Ziaeian B, Yancy CW, Fonarow GC. Association of Optimal Implementation of Sodium-Glucose Cotransporter 2 Inhibitor Therapy With Outcome for Patients With Heart Failure [published online ahead of print, 2020 May 6]. JAMA Cardiol. 2020
Fang JC. Heart-Failure Therapy - New Drugs but Old Habits?. N Engl J Med. 2019
McMurray JJV, Solomon SD, Inzucchi SE, et al. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med. 2019;381(21):1995‐2008.
14 min - Sodium Glucose Transporter-2 (SGLT2) Inhibition to Prevent Cardiotoxicity?
Sodium Glucose Transporter-2 (SGLT2) Inhibition to Prevent Chemotherapy Induced Cardiotoxicity?
Dr RR Baliga's 'Got Knowledge Doc' PodKasts for Physicians
References
Scafoglio C, et al. Functional expression of sodium-glucose transporters in cancer. Proc Natl Acad Sci U S A. 2015
Scafoglio CR, et al. Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma. Sci Transl Med. 2018
Martinez CA, Scafoglio C. Heterogeneity of Glucose Transport in Lung Cancer. Biomolecules. 2020
Paternostro G, Camici PG, Lammerstma AA, Baliga RR, et al. Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography. J Clin Invest. 1996;98(9):2094‐2099.
Bassi NS, Ziaeian B, Yancy CW, Fonarow GC. Association of Optimal Implementation of Sodium-Glucose Cotransporter 2 Inhibitor Therapy With Outcome for Patients With Heart Failure [published online ahead of print, 2020 May 6]. JAMA Cardiol. 2020
Fang JC. Heart-Failure Therapy - New Drugs but Old Habits?. N Engl J Med. 2019
McMurray JJV, Solomon SD, Inzucchi SE, et al. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med. 2019;381(21):1995‐2008.
14 min - Vasoactive Intestinal Peptide (VIP) in Immune Check Point Inhibitor Myocarditis?
Vasoactive Intestinal Peptide (VIP) in Immune Check Point Inhibitor Myocarditis?
Dr RR Baliga's 'Got Knowledge Doc' PodKasts for Physicians
References
Frye BC, Meiss F, von Bubnoff D, Zissel G, Müller-Quernheim J. Vasoactive Intestinal Peptide in Checkpoint Inhibitor-Induced Pneumonitis. N Engl J Med. 2020;382(26):2573-2574. doi:10.1056/NEJMc2000343
Benitez R, Delgado-Maroto V, Caro M, et al. Vasoactive Intestinal Peptide Ameliorates Acute Myocarditis and Atherosclerosis by Regulating Inflammatory and Autoimmune Responses. J Immunol. 2018;200(11):3697-3710. doi:10.4049/jimmunol.1800122 Not Medical Advice or Opinion9 min - Vasoactive Intestinal Peptide (VIP) in Immune Check Point Inhibitor Myocarditis?
Vasoactive Intestinal Peptide (VIP) in Immune Check Point Inhibitor Myocarditis?
Dr RR Baliga's 'Got Knowledge Doc' PodKasts for Physicians
References
Frye BC, Meiss F, von Bubnoff D, Zissel G, Müller-Quernheim J. Vasoactive Intestinal Peptide in Checkpoint Inhibitor-Induced Pneumonitis. N Engl J Med. 2020;382(26):2573-2574. doi:10.1056/NEJMc2000343
Benitez R, Delgado-Maroto V, Caro M, et al. Vasoactive Intestinal Peptide Ameliorates Acute Myocarditis and Atherosclerosis by Regulating Inflammatory and Autoimmune Responses. J Immunol. 2018;200(11):3697-3710. doi:10.4049/jimmunol.1800122 Not Medical Advice or Opinion9 min - Radiation Associated Cardiac Disease (Management)-4
Radiation Associated Cardiac Disease (Management)-4
Dr RR Baliga's "Got Knowledge Doc" Podkasts for PHYSICIANS
Not Medical Advice or Opinion
27 min - Radiation Associated Cardiac Disease (Management)-4
Radiation Associated Cardiac Disease (Management)-4
Dr RR Baliga's "Got Knowledge Doc" Podkasts for PHYSICIANS
Not Medical Advice or Opinion
27 min - Radiation Associated Cardiac Disease (Diagnosis, Screening and Monitoring)-3
Radiation Associated Cardiac Disease (Diagnosis, Screening and Monitoring)-3
Dr RR Baliga's "Got Knowledge Doc" Podkasts for PHYSICIANS
Not Medical Advice or Opinion
24 min - Radiation Associated Cardiac Disease (Diagnosis, Screening and Monitoring)-3
Radiation Associated Cardiac Disease (Diagnosis, Screening and Monitoring)-3
Dr RR Baliga's "Got Knowledge Doc" Podkasts for PHYSICIANS
Not Medical Advice or Opinion
24 min
About Dr RR Baliga's "Got Knowledge Doc" Podkast
From the publisher's feed
"Got Knowledge Doc" Podkast with Dr. RR Baliga
The "Got Knowledge Doc" Podkast, hosted by Dr. Ragavendra R. Baliga, is a knowledge-driven platform designed for physicians and healthcare providers seeking to stay at the forefront of medical science and innovation. With a distinguished career in cardiovascular medicine and academic leadership, Dr. Baliga engages with leading experts to explore cutting-edge research, emerging technologies, and transformative insights in medicine and beyond.
Each episode delves into topics such as cardiology, precision medicine, artificial intelligence in healthcare, epigenetics, and medical ethics—making complex advancements accessible and relevant to clinical practice. Importantly, this podcast is purely educational and does not provide medical advice or clinical opinions.
Join Dr. Baliga and his esteemed guests as they navigate the evolving landscape of medical knowledge, empowering healthcare professionals with evidence-based insights that shape the future of patient care.
More shows like Dr RR Baliga's "Got Knowledge Doc" Podkast
This Week in Cardiology
891 Listeners
The Curbsiders Internal Medicine Podcast
3,352 Listeners
The Mel Robbins Podcast
19,146 Listeners